Big Pharma Fined $3.75 Billion in Fraud Penalties in Fiscal 2013

According to the U.S. Departments of Justice and Health and Human Services, these departments recovered $4.3 billion in criminal and civil fines in the 2013 fiscal year, which ended in September 2013.  This is a $100 million increase from the 2012 fiscal year.  The five-year total in fines has now reached $19.2 billion.  Pharma drugmakers [...]

March 3rd, 2014|Drug and Medical Device Litigation|Comments Off on Big Pharma Fined $3.75 Billion in Fraud Penalties in Fiscal 2013

Takeda’s Future after Losing Actos Patent

In 2012, Takeda’s profit dropped 53% and net profit was down 14% in the last nine months of 2012. Why? Because medical studies have demonstrated the causal connection between Takeda’s flagship diabetes drug Actos and bladder cancer and Takeda also lost its exclusivity patent on its foundation product diabetes treatment.  Actos accounted for more than [...]

August 26th, 2013|Actos Diabetes Drug, Drug and Medical Device Litigation|Comments Off on Takeda’s Future after Losing Actos Patent